<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[MannKind Corp. | Company News & Executive Profiles - MNKD | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/mannkind+corp..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for MannKind Corp.]]></description>
	<s:counts start="0" returned="10" found="16" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Oral-lyn vs. Afresa: How Generex Will Beat Mannkind]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174252-oral-lyn-vs-afresa-how-generex-will-beat-mannkind%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[R.J Steffens submits: As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns regarding diabetes related drug development is safety. The FDA has increasingly issued new alerts from previously approved drugs such as GlaxoSmithKline's GSK Avandia,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 04:19:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/r.j+steffens.html"><![CDATA[R.J Steffens]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">GNBT,MNKD</category>
	</item>
	<item>
		<title><![CDATA[MannKind's CFO Pfeffer Upbeat on Afresa's Future]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005189/mannkind-cfo-pfeffer-upbeat-on-afresas-future/]]></link>
		<description><![CDATA[MannKind Corp.Ã¢â‚¬Ëœs announcement last month that no partnership deal was in the offing for its inhaled-insulin product Afresa this year has lead to widespread commentary about the actual clinical and commercial viability of this investigational prandial drug therapy for diabetes care. In a phone call with me on Wednesday, chief...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Tue, 10 Nov 2009 06:54:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/partnership.html"><![CDATA[Partnership]]></category>
		<category domain="http://resources.bnet.com/topic/cfo.html"><![CDATA[CFO]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind.html"><![CDATA[MannKind]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">MNKD</category>
	</item>
	<item>
		<title><![CDATA[MannKind Corporation Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-359852.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator instructions The first question comes from the line of Michael Tong - Wells Fargo Securities LLC.  Michael Tong - Wells Fargo Securities LLC Can you give us some insight into what you think the timeline for AFRESA and Dreamboat will be? How far...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 02 Nov 2009 18:30:23 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[Agency]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/term.html"><![CDATA[Term]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">MNKD</category>
	</item>
	<item>
		<title><![CDATA[Liking the Risk/Reward in Generex]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F166093-liking-the-risk-reward-in-generex%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Shares of Generex touched just above seventy six cents on above average volume on Monday morning after a New York Times article over the weekend highlighted the company's Ora-Lyn insulin spray product that uses the inside lining of the cheek to deliver insulin to the bloodstream. Mannkind's...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 12 Oct 2009 02:47:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/generex+biotechnology+corp..html"><![CDATA[Generex Biotechnology Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">GNBT,MNKD</category>
	</item>
	<item>
		<title><![CDATA[MannKind Corporation Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-327915.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions Your first question comes from Cory Kasimov - J.P. Morgan. Cory Kasimov - J.P. Morgan I won't ask anything on partnership right now, but I'm wondering from a clinical standpoint, some of the outstanding studies, the commercially focused studies like I think it's...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 03 Aug 2009 18:53:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">MNKD</category>
	</item>
	<item>
		<title><![CDATA[MannKind CorporationÂ Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F153442-mannkind-corporationq2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[MannKind CorporationÂ MNKD   Q2 2009 Earnings Call   August 3, 2009 5:00 pmÂ ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 03 Aug 2009 07:53:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">MNKD</category>
	</item>
	<item>
		<title><![CDATA[MannKind Corporation F1Q09 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-295135.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator (Operator's instruction) Your first question comes from the line of Thomas Wie - Piper Jaffray. Thomas Wie - Piper Jaffray I wanted to get your sense given what you referred to as some of the controversies that people have been raising around the regulatory review. What...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 04 May 2009 19:21:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/term.html"><![CDATA[Term]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">MNKD</category>
	</item>
	<item>
		<title><![CDATA[Zacks Analyst Blog Highlights: Fannie Mae, Freddie Mac, Transocean, Inc., Avon Products and MannKind Corporation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2009_Feb_23/ai_n31373402]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Fannie Mae (NYSE: FNM), Freddie Mac (NYSE: FRE), Transocean, Inc. (NYSE:...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 23 Feb 2009 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fannie+mae.html"><![CDATA[Fannie Mae]]></category>
		<category domain="http://resources.bnet.com/topic/freddie+mac.html"><![CDATA[Freddie Mac]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/new+york+stock+exchange.html"><![CDATA[New York Stock Exchange]]></category>
		<category domain="http://resources.bnet.com/topic/transocean+inc..html"><![CDATA[Transocean Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">FNM,FRE,MNKD</category>
	</item>
	<item>
		<title><![CDATA[MannKind Down to Its Last $28 Million; No Revenue in Sight]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001115/mannkind-down-to-its-last-27-million-no-revenue-in-sight/]]></link>
		<description><![CDATA[MannKind Corp., which burns cash at a rate of $83 million and $75 million per quarter, has only $46.5 billion in current assets left. So it will have to borrow $350 million from Al Mann, the company chairman, to see itself through, according to Zack's. If you check out its...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 20 Feb 2009 14:46:34 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/insulin.html"><![CDATA[Insulin]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/zack.html"><![CDATA[Zack]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">MNKD,PFE</category>
	</item>
	<item>
		<title><![CDATA[MannKind Corporation Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-270227.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Our first question comes from Cory Kasimov with JPMorgan. Cory Kasimov &#8211; JPMorgan Hey, good afternoon guys. Thanks for taking the questions. Actually, my clinical questions are basically answered last week at your Breakfast, but some financial ones here. First of all, can you discuss...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 17 Feb 2009 16:58:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/mannkind+corp..html"><![CDATA[MannKind Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
		<category domain="tickers">JPM,MNKD</category>
	</item>
</channel>
</rss>
